Skip to Main Content

Paper Details

Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
J Neurooncol
36
2016
Brain Tumor, RO4929097, bevacizumab, gliomas, malignant glioma, malignant gliomas, notch, patients
Author NameAffiliation
Thomas J KaleyMemorial Sloan Kettering Cancer Center
Nicholas ButowskiUniversity of California san francisco
Nicholas ButowskiUniversity of California san francisco
Timothy F CloughesyUniversity of California los angeles
Timothy F CloughesyUniversity of California los angeles
  • 1 - 5

Datasets

Release 1.2